| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||
Net loss | |||||||||
-5,539 | -6,163 | -7,167 | -8,069 | -8,449 | -4,524 | -7,086 | -5,877 | -8,311 | -9,454 |
Depreciation and amortization | |||||||||
143 | 109 | 116 | 155 | 211 | 377 | 426 | 416 | 354 | 266 |
Share-based compensation | |||||||||
799 | 1,231 | 1,245 | 1,187 | 1,682 | 880 | 1,458 | 2,031 | 989 | 245 |
Expenses paid through the issuance of common stock | |||||||||
- | 77 | 502 | 62 | 145 | 411 | 140 | 124 | - | 29 |
Gain on change in fair value of derivative liabilities | |||||||||
- | 64 | 24 | - | - | - | - | - | - | - |
Gain from change in fair value of derivative liabilities | |||||||||
- | - | - | 1,065 | 1,539 | 1,549 | 1,686 | -171 | - | 1,227 |
Loss on debt restructuring | |||||||||
- | - | - | -811 | 0 | - | - | - | - | - |
Loss on retirement of equipment | |||||||||
- | - | - | -1 | - | - | - | - | - | - |
Gain on negotiated reductions in account payable | |||||||||
- | - | - | - | - | 77 | 477 | - | - | - |
Gain on sale of intellectual property | |||||||||
- | - | - | - | - | 4,338 | - | - | - | - |
Loss on retirement of equipment | |||||||||
- | - | - | - | -2 | 0 | - | - | - | - |
Loss on loan modification | |||||||||
- | - | - | - | - | - | 1,356 | - | - | - |
Amortization of debt issuance costs and original issue discounts | |||||||||
729 | 562 | 426 | 424 | 471 | 330 | 143 | 2,061 | 1,359 | 889 |
Amortization of lease right of use, net of accretion in lease liabilities | |||||||||
106 | - | - | - | - | - | - | - | - | - |
Increase (decrease) in cash resulting from changes in: | |||||||||
Write-off of costs of withdrawn IPO | |||||||||
- | - | - | - | - | - | - | - | - | 1,788 |
Accounts receivable | |||||||||
-143 | 284 | 83 | -352 | 749 | -301 | 324 | 43 | 370 | 31 |
Inventory, net | |||||||||
1,024 | -122 | 469 | -72 | -68 | 345 | 309 | 270 | -91 | 1,214 |
Cost of deferred product revenue | |||||||||
- | - | - | - | - | - | - | 47 | - | - |
Prepaid expenses and other current assets | |||||||||
143 | 20 | 57 | 37 | 68 | -145 | 63 | 43 | 3 | -38 |
Other assets | |||||||||
-14 | 10 | 0 | 0 | -9 | 0 | 2 | -16 | -4 | -19 |
Accounts payable and accrued expenses | |||||||||
1,165 | -284 | -512 | 178 | -436 | 1,143 | -695 | -2,738 | 2,244 | 3,543 |
Lease liabilities | |||||||||
-108 | - | - | - | - | - | - | - | - | - |
Deferred revenue | |||||||||
863 | 94 | 33 | - | - | - | - | - | - | - |
Deferred revenue | |||||||||
- | - | - | 107 | 13 | -4 | -655 | -3,233 | -2,600 | -2,600 |
Net cash flows from operating activities | |||||||||
- | - | - | - | -8,637 | -7,250 | - | - | - | - |
Net cash flows from operating activities | |||||||||
-2,849 | -4,630 | -5,992 | -5,820 | - | - | -7,777 | -7,433 | -6,239 | -7,707 |
Cash flows from investing activities: | |||||||||
Purchases of property and equipment | |||||||||
10 | 63 | 26 | 101 | 76 | 48 | 74 | 127 | 26 | 61 |
Acquisition of licensing rights | |||||||||
150 | - | - | - | - | - | - | - | - | - |
Net cash flows from investing activities | |||||||||
- | - | - | - | -76 | -48 | - | - | - | - |
Acquisition of license | |||||||||
- | - | - | - | - | - | 100 | - | - | - |
Net cash flows from investing activities | |||||||||
-160 | -63 | -26 | -101 | - | - | -174 | -127 | -26 | -61 |
Cash flows from financing activities: | |||||||||
Proceeds from issuance of 2020 senior secured convertible notes, net of financing costs and discount | |||||||||
7,427 | - | 11,993 | - | - | - | - | - | - | - |
Prepayment of offering costs in connection with January 2020 private placement | |||||||||
75 | - | - | - | - | - | - | - | - | - |
Net proceeds from pre-public unit offerings | |||||||||
- | - | - | - | - | - | - | - | 2,831 | 3,000 |
Net proceeds from issuance of convertible notes payable | |||||||||
- | - | - | - | - | - | - | 3,424 | 2,000 | 3,777 |
Proceeds from private equity offering | |||||||||
- | - | - | - | - | 3,503 | - | 5,516 | - | - |
Net proceeds from equity private placements and exercise of warrants | |||||||||
- | - | - | 3,833 | 4,879 | 9,379 | - | - | - | - |
Cash paid in lieu of issuing fractional shares in reverse split of common stock | |||||||||
- | - | - | -4 | 0 | - | - | - | - | - |
Proceeds from stock option and warrant exercises | |||||||||
- | - | - | - | - | 143 | 19 | - | - | - |
Net cash flows from financing activities | |||||||||
- | - | - | - | 4,879 | 13,026 | - | - | - | - |
Proceeds from exercise of warrants | |||||||||
388 | 505 | - | - | - | - | - | 94 | 2 | - |
Repayment of 2010 junior secured notes payable | |||||||||
2,137 | 2,000 | - | - | - | - | - | - | - | - |
Net cash flows from financing activities | |||||||||
5,604 | -1,494 | 11,993 | 3,828 | - | - | 9,848 | 9,035 | 4,833 | 6,777 |
Net change in cash and cash equivalents | |||||||||
2,594 | -6,188 | 5,974 | -2,092 | -3,835 | 5,727 | 1,896 | 1,474 | -1,431 | -991 |
SUPPLEMENTAL CASH FLOW INFORMATION | |||||||||
Cash paid for: | |||||||||
Income taxes | |||||||||
- | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 49 |
Interest | |||||||||
316 | 210 | 348 | 976 | - | - | - | - | - | - |
Non-Cash Transactions | |||||||||
Interest | |||||||||
- | - | - | - | 223 | 223 | 11 | 33 | 0 | - |
Transfer from inventory to property and equipment | |||||||||
- | - | - | 55 | 94 | 221 | - | - | - | - |
The fair value of the derivatives | |||||||||
- | - | - | 1,207 | - | - | - | - | - | - |
Reduced of derivative liabilities | |||||||||
- | - | - | 37 | - | - | - | - | - | - |
Notes Payable Cancelled, Principal Amount | |||||||||
- | - | - | - | - | 4,338 | - | - | - | - |